Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine for MRD+ ER+/HER2- Breast Cancer
NCT07631052Phase 2Recruiting
- Sponsor
- University Health Network
- Start
- Jul 2026
- Primary completion
- Aug 2029
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in breast cancer, sponsored by University Health Network. Started Jul 2026; status: recruiting.
02
Drugs
capecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07631052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07631052.